Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
2008-10-9
pubmed:abstractText
Primary CNS lymphoma (PCNSL) is an aggressive lymphoma but clinically validated biologic markers that can predict natural history to tailor treatment according to risk are lacking. Several genetic changes including BCL6 rearrangements and deletion of 6q22, containing the putative tumor suppressor gene PTPRK, are potential risk predictors. Herein we determined the prevalence and survival impact of del(6)(q22) and BCL6, immunoglobulin heavy chain (IGH), and MYC gene rearrangements in a large PCNSL cohort treated in a single center.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10337996, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10550299, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10555007, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10659013, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10668897, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10942021, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-10963643, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-11369058, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-11786909, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-11972514, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12387458, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12525518, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12559880, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12591717, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12640061, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12657933, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-12802586, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-14707426, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-15186772, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-15215171, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-15630428, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-15735126, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-15800313, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16009945, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16046532, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16101124, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16240449, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16327438, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16418334, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16525183, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-16896311, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17057753, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17116938, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17122510, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17625604, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17720884, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17989713, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-17989719, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-7742550, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-8055462, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-8142643, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-8167331, http://linkedlifedata.com/resource/pubmed/commentcorrection/18645192-9635710
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4814-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.
pubmed:affiliation
Department of Pathology, CellNetix Pathology, Olympia, WA, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural